Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Nicholas Thompson who wrote (19828)	4/30/1998 1:55:00 AM
From: Flagrante Delictu	Read Replies (2) \| Respond to of 32384

Nicholas, OFF TOPIC. On Sat., 4/25/98, I summarized in posts # 19581 & 19582, the article in the May issue of Bloomberg Magazine written by Michael Gianturco under the title, "Biotech Stocks. Why buy now?" He is president of the asset management firm Princeton Portfolios, science columnist of Forbes, & author of "How to buy Technology Stocks". His thesis is, IMO, a must read to understand why we haven't lifted off yet, but are due. If you do check my synopsis out, disregard my placement of "THE END" . There are several more sentences of his before the real end.